… venous neuropeptide Y that is associated with subsequent heart failure and mortality. …
finding of the present study is that high levels of PV NPY are associated with the development of …

… neuropeptide Y (NPY). Circulating catecholamines predict risk of death in patients with chronic
heart failure (HF… Neuropeptide Y, which has a longer half-life, is an important modulator of …

… we found a greater elevation of BNP in individuals with higher NPY levels at baseline. It is
therefore important that in this much larger study with a total of 362 deaths we found an NPY …

… associated with microvascular dysfunction after ST-elevation myocardial infarction (STEMI). …
of plasma NPY with myocardial function and infarct severity, visualized by cardiac magnetic …

… Both coronary sinus and peripheral venous levels in the ST-elevation myocardial infarction
… of coronary sinus neuropeptide-Y levels in the ST-elevation myocardial infarction group as …

… It is more common with increasing age and other diseases, such as coronary artery
disease (CAD), valvular heart disease, heart failure (HF), and damage to kidney function. …

… Therefore, in the present study, we first characterized the NPY-producing cells in surgically
removed cardiac tissues from patients with chronic heart failure and from mice with AMI. Then…

… myocardial infarction and lastly as STsegment elevation … of plasma neuropeptide Y and
noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure…

… Using the same assay, we have also recently shown in patients with severe heart failure
undergoing implantation of cardiac resynchronization therapy devices, that coronary sinus …

… in patients, which is manifested as the elevation of systemic circulation pressure in clinic and
… in patients with congestive heart failure, and different decreasing levels of plasma NPY after …